Quick Answer
Equillium, Inc. reported Total Revenue of $41.09 million for fiscal year 2024.
Equillium, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | $41.09M +13.9% |
$36.08M +129.0% |
$15.76M | — | — |
| Revenue (ASC 606) | — | $41.09M +13.9% |
$36.08M +129.0% |
$15.76M | — | — |
| Net Income | -$22.40M -177.6% |
-$8.07M +39.5% |
-$13.34M +78.6% |
-$62.43M -59.9% |
-$39.05M -31.0% |
-$29.81M -16.5% |
| Diluted EPS | -$0.39 -69.6% |
-$0.23 +39.5% |
-$0.38 +79.5% |
-$1.85 -36.0% |
-$1.36 | — |
| Total Assets | $31.89M +24.5% |
$25.60M -49.3% |
$50.53M -35.6% |
$78.42M -8.2% |
$85.41M -0.0% |
$85.43M +53.8% |
| Cash and Equivalents | $30.28M +67.4% |
$18.09M -22.1% |
$23.22M -60.7% |
$59.11M +17.4% |
$50.37M +110.0% |
$23.98M +81.4% |
| Stockholders Equity | $28.60M +50.0% |
$19.06M -15.6% |
$22.57M -29.3% |
$31.94M -52.0% |
$66.50M -4.8% |
$69.85M +66.9% |
| R&D Expense | — | — | $37.04M -1.4% |
$37.55M +42.3% |
$26.38M +36.1% |
$19.38M +9.9% |
| Operating Income | -$23.63M -185.8% |
-$8.27M +43.1% |
-$14.52M +76.6% |
-$62.08M -64.3% |
-$37.79M -27.9% |
-$29.55M -10.6% |
| Shares Outstanding | 61.46M +72.9% |
35.56M +0.9% |
35.25M +2.4% |
34.41M +16.8% |
29.46M +19.0% |
24.75M +42.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2024 | $12.16M | +37.1% | -12.2% |
| Revenue (ASC 606) | September 30, 2024 | $12.16M | +37.1% | -12.2% |
| Net Income | September 30, 2025 | -$4.23M | -60328.6% | +26.3% |
| Diluted EPS | September 30, 2025 | -$0.06 | — | +62.5% |
| Total Assets | September 30, 2025 | $34.51M | +0.1% | +178.3% |
| Cash and Equivalents | September 30, 2025 | $33.12M | +114.4% | +188.1% |
| Stockholders Equity | September 30, 2025 | $30.94M | +33.5% | +511.9% |
| R&D Expense | September 30, 2021 | $6.96M | +65.1% | +16.4% |
| Operating Income | September 30, 2025 | -$4.58M | -573.8% | +26.5% |
| Shares Outstanding | September 30, 2025 | 60.68M | +71.3% | +69.9% |
- Equillium, Inc. reported Total Revenue of $41.09 million for fiscal year 2024.
- Equillium, Inc. showed an increase of +13.9% in Total Revenue compared to the prior fiscal year.
- Equillium, Inc. reported Revenue (ASC 606) of $41.09 million for fiscal year 2024.
- Equillium, Inc. showed an increase of +13.9% in Revenue (ASC 606) compared to the prior fiscal year.
- Equillium, Inc. reported Net Income of -$22.40 million for fiscal year 2025.
- Equillium, Inc. showed a decrease of -177.6% in Net Income compared to the prior fiscal year.
- Equillium, Inc. reported Diluted EPS of $0.39 per share (loss) for fiscal year 2025.
- Equillium, Inc. showed a decrease of -69.6% in Diluted EPS compared to the prior fiscal year.
- Equillium, Inc. reported Total Assets of $31.89 million for fiscal year 2025.
- Equillium, Inc. showed an increase of +24.5% in Total Assets compared to the prior fiscal year.
- Equillium, Inc. reported Cash and Equivalents of $30.28 million for fiscal year 2025.
- Equillium, Inc. showed an increase of +67.4% in Cash and Equivalents compared to the prior fiscal year.
- Equillium, Inc. reported Stockholders Equity of $28.60 million for fiscal year 2025.
- Equillium, Inc. showed an increase of +50.0% in Stockholders Equity compared to the prior fiscal year.
- Equillium, Inc. reported R&D Expense of $37.04 million for fiscal year 2023.
- Equillium, Inc. showed a decrease of -1.4% in R&D Expense compared to the prior fiscal year.
- Equillium, Inc. reported Operating Income of -$23.63 million for fiscal year 2025.
- Equillium, Inc. showed a decrease of -185.8% in Operating Income compared to the prior fiscal year.
- Equillium, Inc. reported Shares Outstanding of 61.46 million shares for fiscal year 2025.
- Equillium, Inc. showed an increase of +72.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: